EU life sciences regulatory reform featuring biotechnology, pharmaceutical legislation, health data, health technology assessment and AI governance.

By:
On:
In: Life Sciences & Healthcare

Europe is reworking the rules governing biotechnology, pharmaceuticals, clinical evidence, health data and artificial intelligence. For life sciences companies, the challenge is no longer just regulatory compliance. It is understanding how these interconnected frameworks will influence innovation, investment, manufacturing and patient access. Europe is entering a consequential period of changeContinue Reading

Workers in a pharmaceutical facility packaging tablets in Islamabad.

By:
On:
In: Life Sciences & Healthcare

The global life sciences industry is entering one of the most transformative periods in its history. From artificial intelligence and precision medicine to biologics, digital laboratories, and sustainable biomanufacturing, the sector is evolving far beyond traditional pharmaceutical research and healthcare delivery. What was once an industry driven largely by laboratoryContinue Reading